Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.380
+0.080 (6.15%)
At close: Mar 9, 2026, 4:00 PM EDT
1.350
-0.030 (-2.17%)
After-hours: Mar 9, 2026, 7:29 PM EDT
RANI Revenue
Rani Therapeutics Holdings had revenue of $1.20M in the twelve months ending September 30, 2025. In the year 2024, Rani Therapeutics Holdings had annual revenue of $1.03M.
Revenue (ttm)
$1.20M
Revenue Growth
n/a
P/S Ratio
139.75
Revenue / Employee
$11,321
Employees
106
Market Cap
167.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 146.07M |
| Zentalis Pharmaceuticals | 26.87M |
| Innate Pharma | 14.84M |
| Caribou Biosciences | 11.16M |
| Tonix Pharmaceuticals Holding | 10.30M |
| Fate Therapeutics | 6.65M |
RANI News
- 5 weeks ago - Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer - GlobeNewsWire
- 2 months ago - Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen - GlobeNewsWire
- 3 months ago - Rani Therapeutics to Participate in the Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewsWire
- 4 months ago - Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - GlobeNewsWire
- 4 months ago - Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors - GlobeNewsWire
- 4 months ago - Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai - Seeking Alpha